(S)-Methyl 2-((S)-2-((2S,3R)-3-Amino-S-(2-chlorophenoxy)-2-hydroxypentanamido)-4-methylpentanamido)-3-(4-hydroxyphenyl)propanoate

ID: ALA5197001

Chembl Id: CHEMBL5197001

PubChem CID: 168285580

Max Phase: Preclinical

Molecular Formula: C27H36ClN3O7

Molecular Weight: 550.05

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)CCOc1cccc(Cl)c1

Standard InChI:  InChI=1S/C27H36ClN3O7/c1-16(2)13-22(25(34)31-23(27(36)37-3)14-17-7-9-19(32)10-8-17)30-26(35)24(33)21(29)11-12-38-20-6-4-5-18(28)15-20/h4-10,15-16,21-24,32-33H,11-14,29H2,1-3H3,(H,30,35)(H,31,34)/t21-,22+,23+,24+/m1/s1

Standard InChI Key:  YHYCZFIGZSESIE-SBFWRKJZSA-N

Alternative Forms

  1. Parent:

    ALA5197001

    ---

Associated Targets(Human)

ERAP1 Tchem Endoplasmic reticulum aminopeptidase 1 (581 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ERAP2 Tchem Endoplasmic reticulum aminopeptidase 2 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IL1RN Tchem Interleukin-1 receptor antagonist protein (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 550.05Molecular Weight (Monoisotopic): 549.2242AlogP: 1.93#Rotatable Bonds: 14
Polar Surface Area: 160.21Molecular Species: NEUTRALHBA: 8HBD: 5
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.50CX Basic pKa: 8.47CX LogP: 2.19CX LogD: 1.29
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.22Np Likeness Score: -0.03

References

1. Vourloumis D, Mavridis I, Athanasoulis A, Temponeras I, Koumantou D, Giastas P, Mpakali A, Magrioti V, Leib J, van Endert P, Stratikos E, Papakyriakou A..  (2022)  Discovery of Selective Nanomolar Inhibitors for Insulin-Regulated Aminopeptidase Based on α-Hydroxy-β-amino Acid Derivatives of Bestatin.,  65  (14.0): [PMID:35833347] [10.1021/acs.jmedchem.2c00904]

Source